{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:00:48Z","timestamp":1792674048606,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.yjmcc.2020.02.006","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T11:39:40Z","timestamp":1582112380000},"page":"30-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["IRF-1 mediates the suppressive effects of mTOR inhibition on arterial endothelium"],"prefix":"10.1016","volume":"140","author":[{"given":"Kai","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiannan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingxi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G.","family":"Passerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott I.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChongXiu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yjmcc.2020.02.006_bb0005","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.amjmed.2006.01.023","article-title":"Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials","volume":"119","author":"Bavry","year":"2006","journal-title":"Am. J. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.02.006_bb0010","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.02.006_bb0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jcmg.2009.01.011","article-title":"One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis","volume":"2","author":"Nakazawa","year":"2009","journal-title":"J. Am. Coll. Cardiol. Img."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.02.006_bb0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"Vezina","year":"1975","journal-title":"The Journal of Antibiotics"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.02.006_bb0025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.yjmcc.2020.02.006_bb0030","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1073\/pnas.1320265111","article-title":"Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells","volume":"111","author":"Hoshii","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"24","key":"10.1016\/j.yjmcc.2020.02.006_bb0035","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00418-17","article-title":"The mTOR-Bach2 cascade controls cell cycle and class switch recombination during B cell differentiation","volume":"37","author":"Tamahara","year":"2017","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.02.006_bb0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cell.2004.12.040","article-title":"The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation","volume":"120","author":"Beuvink","year":"2005","journal-title":"Cell"},{"issue":"35","key":"10.1016\/j.yjmcc.2020.02.006_bb0045","doi-asserted-by":"crossref","first-page":"36490","DOI":"10.1074\/jbc.M401208200","article-title":"Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity","volume":"279","author":"Huang","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.02.006_bb0050","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1356-9597.2004.00727.x","article-title":"Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function","volume":"9","author":"Oshiro","year":"2004","journal-title":"Genes to Cells"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.02.006_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.02.006_bb0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/0008-5472.CAN-09-2340","article-title":"Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2","volume":"70","author":"Yu","year":"2010","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.yjmcc.2020.02.006_bb0065","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1093\/nar\/19.16.4421","article-title":"Activation of IFN-beta element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis","volume":"19","author":"Watanabe","year":"1991","journal-title":"Nucleic Acids Res."},{"issue":"22","key":"10.1016\/j.yjmcc.2020.02.006_bb0070","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1158\/0008-5472.CAN-04-2223","article-title":"Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin","volume":"64","author":"Pizzoferrato","year":"2004","journal-title":"Cancer Res."},{"issue":"26","key":"10.1016\/j.yjmcc.2020.02.006_bb0075","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1038\/sj.onc.1209402","article-title":"Interferon-gamma induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors","volume":"25","author":"Egwuagu","year":"2006","journal-title":"Oncogene"},{"issue":"6541","key":"10.1016\/j.yjmcc.2020.02.006_bb0080","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/376596a0","article-title":"An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes","volume":"376","author":"Tamura","year":"1995","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.yjmcc.2020.02.006_bb0085","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/cdd.2009.156","article-title":"IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells","volume":"17","author":"Gao","year":"2010","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.02.006_bb0090","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1158\/0008-5472.CAN-06-3564","article-title":"Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1","volume":"67","author":"Kroger","year":"2007","journal-title":"Cancer Res."},{"issue":"29","key":"10.1016\/j.yjmcc.2020.02.006_bb0095","doi-asserted-by":"crossref","first-page":"26589","DOI":"10.1074\/jbc.M301491200","article-title":"The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter","volume":"278","author":"Xie","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.02.006_bb0100","doi-asserted-by":"crossref","first-page":"H408","DOI":"10.1152\/ajpheart.00411.2018","article-title":"Downregulation of GATA6 in mTOR-inhibited human aortic endothelial cells: effects on TNF-alpha-induced VCAM-1 expression and monocytic cell adhesion","volume":"316","author":"Fan","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.02.006_bb0105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1006\/geno.1994.1202","article-title":"Molecular characterization of the gene for human interleukin-1 beta converting enzyme (IL1BC)","volume":"20","author":"Cerretti","year":"1994","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.yjmcc.2020.02.006_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.110.988915","article-title":"Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration","volume":"124","author":"Sun","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.yjmcc.2020.02.006_bb0115","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/ATVBAHA.118.312263","article-title":"Cell-specific effects of GATA (GATA zinc finger transcription factor family)-6 in vascular smooth muscle and endothelial cells on vascular injury neointimal formation","volume":"39","author":"Zhuang","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.02.006_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/eurheartj\/ehp259","article-title":"Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents","volume":"31","author":"Camici","year":"2010","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.yjmcc.2020.02.006_bb0125","doi-asserted-by":"crossref","first-page":"11991","DOI":"10.1074\/jbc.M109.066621","article-title":"Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1","volume":"285","author":"Moss","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.02.006_bb0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ijc.23109","article-title":"EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells","volume":"122","author":"Andersen","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"20","key":"10.1016\/j.yjmcc.2020.02.006_bb0135","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1128\/MCB.00611-08","article-title":"CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1","volume":"28","author":"Moschonas","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"7025","key":"10.1016\/j.yjmcc.2020.02.006_bb0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature03205","article-title":"Regulation of cap-dependent translation by eIF4E inhibitory proteins","volume":"433","author":"Richter","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.02.006_bb0145","doi-asserted-by":"crossref","first-page":"F418","DOI":"10.1152\/ajprenal.90319.2008","article-title":"mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes","volume":"296","author":"Vollenbroker","year":"2009","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.02.006_bb0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.yjmcc.2020.02.006_bb0155","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1096\/fj.201500042","article-title":"Up-regulation of the mammalian target of rapamycin complex 1 subunit raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension","volume":"30","author":"Aghamohammadzadeh","year":"2016","journal-title":"FASEB Journal"},{"issue":"1","key":"10.1016\/j.yjmcc.2020.02.006_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2015.05.097","article-title":"Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1","volume":"464","author":"Ha","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.yjmcc.2020.02.006_bb0165","first-page":"3373","article-title":"p53\/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin","volume":"61","author":"Huang","year":"2001","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.02.006_bb0170","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/mol.65.4.880","article-title":"Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties","volume":"65","author":"Zohlnhofer","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.02.006_bb0175","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/j.1476-5381.2011.01734.x","article-title":"Kruppel-like factor 4 is induced by rapamycin and mediates the anti-proliferative effect of rapamycin in rat carotid arteries after balloon injury","volume":"165","author":"Wang","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"36","key":"10.1016\/j.yjmcc.2020.02.006_bb0180","doi-asserted-by":"crossref","first-page":"24341","DOI":"10.1074\/jbc.M109.033530","article-title":"Inactivation of mammalian target of rapamycin increases STAT1 nuclear content and transcriptional activity in alpha4- and protein phosphatase 2A-dependent fashion","volume":"284","author":"Fielhaber","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.02.006_bb0185","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.20131125","article-title":"Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2","volume":"211","author":"Wang","year":"2014","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.02.006_bb0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.HYP.33.1.162","article-title":"Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells","volume":"33","author":"Horiuchi","year":"1999","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.yjmcc.2020.02.006_bb0195","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/SHK.0000000000000595","article-title":"Interferon regulatory Factor-1 mediates alveolar macrophage pyroptosis during LPS-induced acute lung injury in mice","volume":"46","author":"Wu","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.yjmcc.2020.02.006_bb0200","doi-asserted-by":"crossref","first-page":"10255","DOI":"10.1038\/ncomms10255","article-title":"mTORC1-independent raptor prevents hepatic steatosis by stabilizing PHLPP2","volume":"7","author":"Kim","year":"2016","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.02.006_bb0205","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ncb3407","article-title":"Protein kinase C controls lysosome biogenesis independently of mTORC1","volume":"18","author":"Li","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.02.006_bb0210","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.molcel.2006.08.002","article-title":"Cell signaling and function organized by PB1 domain interactions","volume":"23","author":"Moscat","year":"2006","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.yjmcc.2020.02.006_bb0215","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.celrep.2016.04.051","article-title":"PDK1 is a regulator of epidermal differentiation that activates and organizes asymmetric cell division","volume":"15","author":"Dainichi","year":"2016","journal-title":"Cell Rep."},{"issue":"19","key":"10.1016\/j.yjmcc.2020.02.006_bb0220","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0960-9822(98)70444-0","article-title":"Regulation of protein kinase C zeta by PI 3-kinase and PDK-1","volume":"8","author":"Chou","year":"1998","journal-title":"Current Biology"},{"issue":"10","key":"10.1016\/j.yjmcc.2020.02.006_bb0225","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1161\/ATVBAHA.113.301659","article-title":"Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-alpha activation and disruption of the p120-vascular endothelial cadherin interaction","volume":"33","author":"Habib","year":"2013","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.02.006_bb0230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1074248410382106","article-title":"Therapeutic potential for protein kinase C inhibitor in vascular restenosis","volume":"16","author":"Ding","year":"2011","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.yjmcc.2020.02.006_bb0235","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0024-3205(95)02329-1","article-title":"Protein kinase C-alpha regulates proliferation but not apoptosis in rat coronary vascular smooth muscle cells","volume":"58","author":"Leszczynski","year":"1996","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.02.006_bb0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0002-9440(10)65260-1","article-title":"Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer","volume":"154","author":"Cornford","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"16","key":"10.1016\/j.yjmcc.2020.02.006_bb0245","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1073\/pnas.1221799110","article-title":"c-Myc phosphorylation by PKCzeta represses prostate tumorigenesis","volume":"110","author":"Kim","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.yjmcc.2020.02.006_bb0250","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/sj.cdd.4401823","article-title":"PKCzeta at the crossroad of NF-kappaB and Jak1\/Stat6 signaling pathways","volume":"13","author":"Moscat","year":"2006","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.02.006_bb0255","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.4049\/jimmunol.174.9.5823","article-title":"Inhibition of mammalian target of rapamycin potentiates thrombin-induced intercellular adhesion molecule-1 expression by accelerating and stabilizing NF-kappa B activation in endothelial cells","volume":"174","author":"Minhajuddin","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.02.006_bb0260","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0741-5214(98)70273-3","article-title":"Protein kinase C isoforms in human aortic smooth muscle cells","volume":"27","author":"Grange","year":"1998","journal-title":"J. Vasc. Surg."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.02.006_bb0265","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/01.RES.0000179767.37838.60","article-title":"Endothelial protein kinase C isoform identity and differential activity of PKCzeta in an athero-susceptible region of porcine aorta","volume":"97","author":"Magid","year":"2005","journal-title":"Circ. Res."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820300432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820300432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:29:09Z","timestamp":1758313749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282820300432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":53,"alternative-id":["S0022282820300432"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.02.006","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IRF-1 mediates the suppressive effects of mTOR inhibition on arterial endothelium","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}